Retinal Vein Occlusion: all 291 studies
Page 3 of 3. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and OxymapCompletedNCT02521116Not applicable
- Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionStatus unknownNCT02486484Phase 2
- Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein OcclusionCompletedNCT02478515Phase 4
- Hyperbaric Chamber for Central Retinal Vein Occlusion (CRVO) PatientsStatus unknownNCT02405741Phase 2
- Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVOCompletedNCT02387788Phase 2
- Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend RegimenCompletedNCT02274259Phase 4
- Retinal Thrombosis and AtherosclerosisStatus unknownNCT02257333
- Retinal Vessel Diameter in Branch Retinal Vein OcclusionCompletedNCT02215109
- Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase IStatus unknownNCT02173873Phase 1
- Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein OcclusionStatus unknownNCT02169648Not applicable
- Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein OcclusionCompletedNCT02144662Not applicable
- Resistance to Antibiotics in Patients Receiving Eye InjectionsCompletedNCT02126423
- Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVOStatus unknownNCT02091505Not applicable
- Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the RetinaTerminatedNCT02088151Not applicable
- Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO)CompletedNCT02040220
- Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein OcclusionCompletedNCT02033031Phase 3
- OCT in Retinal Vein OcclusionsCompletedNCT01992575
- Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular DiseasesStatus unknownNCT01975103Phase 2
- Ranibizumab Treatment for Retinal Vein OcclusionStatus unknownNCT01968616Not applicable
- Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCTCompletedNCT01968239Phase 2
- Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGFTerminatedNCT01946399Not applicable
- Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)TerminatedNCT01875770
- NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein OcclusionsCompletedNCT01870427Phase 4
- Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF TherapyStatus unknownNCT01857544Phase 4
- Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein OcclusionStatus unknownNCT01827722Phase 4
- Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein OcclusionStatus unknownNCT01809236Phase 2
- Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair VisionTerminatedNCT01795209Phase 4
- Vitamin D Levels in Patients With Central Retinal Vein Occlusion- a Prospective Controlled StudyCompletedNCT01793181
- Diameters and Wall-to-lumen Ratio of Retinal Arterioles in Patients With Retinal Vein Occlusion.CompletedNCT01789437Not applicable
- Dexamethasone-implant for the Treatment of RVOCompletedNCT01767545Phase 4
- Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy SubjectsStatus unknownNCT01746615Not applicable
- Impact of Intravitreal Aflibercept Injections on Capillary Non-PerfusionCompletedNCT01724554Phase 1/2
- Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular ImagingTerminatedNCT01717937
- The Effectiveness of Intravitreal Avastin Injection for CRVOStatus unknownNCT01678248
- DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)CompletedNCT01662518Phase 1/2
- Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)Status unknownNCT01635803Phase 2/3
- Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein OcclusionCompletedNCT01581411Phase 1
- Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein OcclusionStatus unknownNCT01581151Not applicable
- A Long-Term Safety Study of OZURDEX® in Clinical PracticeCompletedNCT01539577
- A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the EyeStatus unknownNCT01531842Not applicable
- Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)CompletedNCT01512901Phase 2/3
- Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein OcclusionCompletedNCT01448018Phase 4
- Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein OcclusionCompletedNCT01428388Not applicable
- Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein OcclusionCompletedNCT01377597Phase 3
- Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal RanibizumabCompletedNCT01360385
- Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human EyeStatus unknownNCT01348633
- Observe the Effectiveness and Safety of Ranibizumab in Real Life SettingCompletedNCT01318941
- Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)Status unknownNCT01303276
- Obstructive Sleep Apnea, Retinal Vein Occlusion, Retinal Artery OcclusionStatus unknownNCT01291862Not applicable
- Anatomic Outcomes Following Ozurdex InjectionsCompletedNCT01282411
- Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)Status unknownNCT01189526Phase 3
- Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)Status unknownNCT01178697Phase 2
- Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein OcclusionStatus unknownNCT01123564Phase 2
- Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor VisionCompletedNCT01053858Not applicable
- Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein OcclusionStatus unknownNCT01044329Phase 2
- Lucentis for Macular Edema Associated With Central Retinal Vein OcclusionCompletedNCT01028248Phase 1
- Ranibizumab in Patients With Branch Retinal Vein OcclusionCompletedNCT01027481Phase 4
- Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein OcclusionStatus unknownNCT01011374Phase 1
- Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein OcclusionCompletedNCT00970957Phase 3
- Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein OcclusionTerminatedNCT00969293Phase 1
- Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)CompletedNCT00942864Phase 3
- Bevacizumab for Central Retinal Vein Occlusion StudyCompletedNCT00906685Phase 3
- Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis EvaluationsCompletedNCT00831350Phase 2
- Combined Triple Procedure in Retinal Vein Occlusion (RVO)CompletedNCT00805064Phase 3
- Transcorneal Electrical Stimulation Therapy for Retinal DiseaseCompletedNCT00804102Not applicable
- Parnaparin vs Aspirin in the Treatment of Retinal Vein OcclusionTerminatedNCT00732927Phase 3
- Vitrectomy for Branch Retinal Vein OcclusionCompletedNCT00685490
- Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)TerminatedNCT00642226Phase 3
- Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)CompletedNCT00636493Early Phase 1
- Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein OcclusionCompletedNCT00612261Not applicable
- A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVOCompletedNCT00567697Phase 3
- Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVOTerminatedNCT00566761Phase 4
- Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)CompletedNCT00562406Not applicable
- A Pilot Study of Functional Optical Coherence Tomography for Ocular ImagingCompletedNCT00556114
- The ROVO Study: Radial Optic Neurotomy for CVOCompletedNCT00532142Phase 2/3
- Atorvastatin for the Treatment of Retinal Vein OcclusionStatus unknownNCT00517257Phase 3
- Lucentis for Central Retinal Vein Occlusion (CRVO)CompletedNCT00406796Phase 1
- Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein OcclusionCompletedNCT00406471Phase 1
- Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular EdemaCompletedNCT00403039Phase 1
- Retinal Endo Vascular Surgery for Central Retinal Vein OcclusionStatus unknownNCT00383773Not applicable
- Radial Optic Neurotomy in Central Retinal Vein Occlusion : a Randomized TrialTerminatedNCT00379223Not applicable
- Intravitreal Triamcinolone for Acute Branch Retinal Vein OcclusionCompletedNCT00370266Phase 2
- A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein OcclusionCompletedNCT00308477Phase 1/2
- Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).TerminatedNCT00211471Phase 2
- Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)WithdrawnNCT00211354Phase 2
- Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel BlockageCompletedNCT00106132Phase 3
- Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNCT00101764Phase 1
- Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)CompletedNCT00088283Phase 2
- Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel DisordersCompletedNCT00071227Phase 1
- Research Study in Patients With Persistent Macular EdemaCompletedNCT00035906Phase 2
- Central Vein Occlusion Study (CVOS)CompletedNCT00000131Phase 3